The role of dose density in combination cancer chemotherapy
From MaRDI portal
Publication:2207098
DOI10.1016/j.cnsns.2019.104918OpenAlexW2956639026MaRDI QIDQ2207098
Antônio M. Batista, Kelly C. Iarosz, Jesús M. Seoane, Miguel A. F. Sanjuán, Álvaro G. López, Ricardo L. Viana
Publication date: 22 October 2020
Published in: Communications in Nonlinear Science and Numerical Simulation (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/1904.03410
Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50) Computational methods for problems pertaining to biology (92-08)
Related Items (3)
Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach ⋮ The effect of time ordering and concurrency in a mathematical model of chemoradiotherapy ⋮ Mathematical model of brain tumour growth with drug resistance
Cites Work
- A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy
- A mathematical model of drug resistance: Heterogeneous tumors
- The dose-dense principle in chemotherapy
- A mathematical model of cycle-specific chemotherapy
- Destruction of solid tumors by immune cells
- ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
This page was built for publication: The role of dose density in combination cancer chemotherapy